stockrowTelesis Bio Inc.
TBIO Healthcare Medical Devices
Telesis Bio Inc.’s revenue for fiscal 2023 (year ended December 2023) was $27.5 million, roughly unchanged from fiscal 2022.
Follow TBIO
Alert me
Telesis Bio Inc. (TBIO) EV/Sales
As of 6 November 2026, Telesis Bio Inc. (TBIO) trades at a EV/Sales of 0.1×. Over the past ten years it has ranged from −2.5× (September 2021) to 26.4× (October 2021); the current reading is higher than 33% of that period. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2023 | −0.1× | — |
| FY2022 | 0.5× | (97.72%) |
| FY2021 | 22.8× | 18.43% |
| FY2020 | 19.3× | 0.00% |
| FY2020 | 19.3× | 0.00% |
| FY2019 | 19.3× | 0.00% |
| FY2019 | 19.3× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2024 | 0.6× | 524.42% |
| Jun 2024 | 0.1× | (10.92%) |
| Mar 2024 | 0.1× | — |
| Dec 2023 | −0.1× | — |
| 14 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NVNO enVVeno Medical Corporation compare | −50.8× |
| TNON Tenon Medical, Inc. compare | −0.2× |
| WOK WORK Medical Technology Group LTD compare | n/m |
| BDMD Baird Medical Investment Holdings Limited compare | n/m |
| TBIO Telesis Bio Inc. | 0.1× |
| INBS Intelligent Bio Solutions Inc. compare | 0.3× |
| BMRA Biomerica, Inc. compare | 0.6× |
| TRIB Trinity Biotech PLC compare | 3.0× |
| VNRX VolitionRX Limited compare | 4.1× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)